|

The COCCOS Study: a Transition Program for Young Persons With Chronic Conditions

RECRUITINGN/ASponsored by Universiteit Antwerpen
Actively Recruiting
PhaseN/A
SponsorUniversiteit Antwerpen
Started2025-03-13
Est. completion2026-12
Eligibility
Age16 Years – 21 Years
Healthy vol.Accepted

Summary

A study is undertaken to examine the feasibility of the newly developed transition program in adolescents with type 1 diabetes, asthma and obesity in a multicentric setting. Specific objectives for this study are: (1) examining the impact of the program in terms of patient-reported health outcomes, (2) examining patients' and healthcare providers' experiences related to the program implementation process, and (3) examining the impact of the program in terms of cost-effectiveness.

Eligibility

Age: 16 Years – 21 YearsHealthy volunteers accepted
Inclusion criteria:

For participants in the intervention group (IG):

* 17 years old;
* diagnosed with type 1 diabetes, asthma and/or obesity;
* who had at least one pediatric outpatient visit, prior to inclusion, in one of both hospitals within the past 12 months;
* are Dutch speaking;
* planned to transfer to adult care within the next 12 months.

For participants in the control group (CG):

* age 17,5 and 18 years old, as the control period has a shorter duration (4 months vs. 12 months)
* diagnosed with type 1 diabetes, asthma and/or obesity;
* who had at least one pediatric outpatient visit, prior to inclusion, in one of both hospitals within the past 12 months;
* are Dutch speaking;
* planned to transfer to adult care within the next 12 months.

Exclusion criteria:

Applicable for both CG and IG:

\- patients with severe mental, cognitive or neurological problems will be excluded

Conditions4

AsthmaDiabetesObesityType 1 Diabetes Mellitus

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.